Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
For someone starting at 8.0%, this could mean reaching 6.5-7.0%, potentially meeting treatment targets
Product Attributes CAS # : 1415456-99-3 Molecular Formula : C171H266N42O55S2 Sequence (AA) : KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY Molecular Weight : ~3789 g/mol Half-Life : ~159 hours (~7 days) Synonyms : AM833, NN9838, Long-acting amylin analog Type : Synthetic research peptide (amylin receptor agonist) Research Focus : Weight Management & Metabolic Regulation, Appetite & Satiety Scientific References Effect of cagrilintide alone or in combination with smglutd on body weight Human RCT Smglutd and cagrilintide in adults with overweight or obesity Human RCT Pharmacokinetics and tolerability of cagrilintide in subjects with overweight or obesity Human RCT Cagrilintide plus smglutd for obesity management Human RCT Amylin agonists in the treatment of obesity Observational | Animal Amylin and amylin analogs: regulation of food intake and body weight Animal | In vitro Combination therapy for obesity: incretin and amylin pathways Observational Cagrilintide overview: mechanism, evidence, and dosage Observational | Human RCT Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
Slowing Gastric Emptying : GLP-1 also works by slowing down the emptying of the stomach, leading to a feeling of fullness that persists for a longer duration
Excretion Pathways Limited data exists on specific excretion pathways for topically applied Syn-AKE: Degradation products likely eliminated through normal peptide metabolic pathways Renal clearance probable for any systemically absorbed peptide or fragments No accumulation detected in repeated-use studies (manufacturer data) Excretion kinetics require further investigation through labeled peptide studies The reversible nature of Syn-AKEs effects and absence of reported accumulation issues suggest efficient clearance mechanisms, though detailed elimination studies are lacking in peer-reviewed literature
It is available in two forms: oral tablets and injections
